DK1007024T3 - Doseringsformer af sertralin med forsinket frigivelse - Google Patents

Doseringsformer af sertralin med forsinket frigivelse

Info

Publication number
DK1007024T3
DK1007024T3 DK98923022T DK98923022T DK1007024T3 DK 1007024 T3 DK1007024 T3 DK 1007024T3 DK 98923022 T DK98923022 T DK 98923022T DK 98923022 T DK98923022 T DK 98923022T DK 1007024 T3 DK1007024 T3 DK 1007024T3
Authority
DK
Denmark
Prior art keywords
delayed
dosage forms
release sertraline
sertraline
release
Prior art date
Application number
DK98923022T
Other languages
English (en)
Inventor
William John Curatolo
Hylar Lewis Friedman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1007024(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1007024T3 publication Critical patent/DK1007024T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
DK98923022T 1997-07-01 1998-06-16 Doseringsformer af sertralin med forsinket frigivelse DK1007024T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01
PCT/IB1998/000937 WO1999001122A1 (en) 1997-07-01 1998-06-16 Delayed-release dosage forms of sertraline

Publications (1)

Publication Number Publication Date
DK1007024T3 true DK1007024T3 (da) 2003-11-17

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923022T DK1007024T3 (da) 1997-07-01 1998-06-16 Doseringsformer af sertralin med forsinket frigivelse

Country Status (41)

Country Link
EP (1) EP1007024B1 (da)
JP (1) JP3786715B2 (da)
KR (1) KR100369698B1 (da)
CN (4) CN1494899A (da)
AP (1) AP1199A (da)
AR (1) AR038394A2 (da)
AT (1) ATE245415T1 (da)
AU (1) AU727152B2 (da)
BG (1) BG64742B1 (da)
BR (1) BR9809895A (da)
CA (1) CA2290969C (da)
DE (1) DE69816624T2 (da)
DK (1) DK1007024T3 (da)
DZ (1) DZ2547A1 (da)
EA (1) EA001906B1 (da)
ES (1) ES2202858T3 (da)
GT (1) GT199800091A (da)
HK (1) HK1027982A1 (da)
HN (1) HN1998000099A (da)
HR (1) HRP980376B1 (da)
HU (1) HUP0301787A3 (da)
ID (1) ID23187A (da)
IL (2) IL152304A0 (da)
IS (1) IS5267A (da)
MA (1) MA24585A1 (da)
NO (1) NO996519L (da)
NZ (1) NZ501249A (da)
OA (1) OA11247A (da)
PA (1) PA8454201A1 (da)
PE (1) PE84399A1 (da)
PL (1) PL337799A1 (da)
PT (1) PT1007024E (da)
SI (1) SI1007024T1 (da)
SK (1) SK173299A3 (da)
TN (1) TNSN98122A1 (da)
TR (1) TR199903295T2 (da)
TW (1) TW575437B (da)
UA (1) UA63953C2 (da)
UY (1) UY25068A1 (da)
WO (1) WO1999001122A1 (da)
ZA (1) ZA985710B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1126826E (pt) 1998-11-02 2008-11-25 Elan Pharma Int Ltd Composição de metilfenidato de libertação modificada multiparticulada
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
ATE318135T1 (de) 1999-09-03 2006-03-15 Apbi Holdings Llc Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
IL150850A0 (en) * 2000-02-10 2003-02-12 Bpsi Holdings Inc Enteric coating compositions containing acrylic resin
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
EP1377276B1 (en) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Timed pulse release composition
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
PT1007024E (pt) 2003-11-28
ATE245415T1 (de) 2003-08-15
MA24585A1 (fr) 1998-12-31
SI1007024T1 (en) 2003-12-31
CN1475209A (zh) 2004-02-18
PL337799A1 (en) 2000-09-11
HN1998000099A (es) 1998-10-22
CN1261273A (zh) 2000-07-26
NO996519L (no) 2000-02-29
CN1494899A (zh) 2004-05-12
HUP0301787A3 (en) 2005-04-28
SK173299A3 (en) 2000-11-07
KR100369698B1 (ko) 2003-01-30
DZ2547A1 (fr) 2003-02-08
AP9801278A0 (en) 1998-06-30
ID23187A (id) 2000-03-23
TW575437B (en) 2004-02-11
JP2000513751A (ja) 2000-10-17
IL133081A (en) 2005-09-25
EP1007024B1 (en) 2003-07-23
NZ501249A (en) 2001-06-29
CN1475208A (zh) 2004-02-18
AR038394A2 (es) 2005-01-12
KR20010013522A (ko) 2001-02-26
AU727152B2 (en) 2000-12-07
EA001906B1 (ru) 2001-10-22
UY25068A1 (es) 2000-12-29
HK1027982A1 (en) 2001-02-02
IS5267A (is) 1999-11-23
CN1151783C (zh) 2004-06-02
EP1007024A1 (en) 2000-06-14
NO996519D0 (no) 1999-12-28
ZA985710B (en) 2000-01-10
ES2202858T3 (es) 2004-04-01
PA8454201A1 (es) 2000-09-29
BR9809895A (pt) 2000-08-01
WO1999001122A1 (en) 1999-01-14
OA11247A (en) 2002-11-19
CA2290969C (en) 2004-02-17
JP3786715B2 (ja) 2006-06-14
AU7545198A (en) 1999-01-25
PE84399A1 (es) 1999-09-11
TNSN98122A1 (fr) 2005-03-15
CA2290969A1 (en) 1999-01-14
HUP0301787A2 (hu) 2003-11-28
AP1199A (en) 2003-08-28
HRP980376A2 (en) 1999-04-30
DE69816624T2 (de) 2004-02-19
BG64742B1 (bg) 2006-02-28
UA63953C2 (uk) 2004-02-16
TR199903295T2 (xx) 2000-08-21
HRP980376B1 (en) 2002-12-31
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
DE69816624D1 (de) 2003-08-28
IL133081A0 (en) 2001-03-19
BG103916A (en) 2000-07-31
EA199900965A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
FI955681A (fi) Masennuslääkkeen annostusmuoto
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
DK1032566T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0908449T3 (da) Fremstilling af carotenoider
DK1007024T3 (da) Doseringsformer af sertralin med forsinket frigivelse
DK1121116T3 (da) Farmaceutisk præparat af fluvastatin med opretholdt frigivelse
DK0975217T3 (da) Synergistiske blandinger af udvalgte aminosyrer
DK1005444T3 (da) Fremgangsmåde til fremstilling af aromatiske aminer
DE69700800T2 (de) Reinigung von Nitrile
DK0980241T3 (da) Gelatineindkapslede opløsningsdosisformer af sertralin
NO996520D0 (no) Opploeste sertralinblandinger
DE69734836D1 (de) Projektionsuhr
DK1011678T3 (da) Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
DK1015442T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
DK1000052T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
ATA128198A (de) Dusche
DK0988263T3 (da) Fremgangsmåde til fremstilling af radioioderede neuroreceptormidler
ZA985707B (en) Sertraline salts and sustained-release dosage forms of sertraline.
DK199901540A (da) Forbedret syntese af sertralin
DK0923293T3 (da) Behandling af diarré
DK1009245T3 (da) Fremstilling af fyldt pasta
BR9704505A (pt) Chuveiro para higiene íntima